November 29, 2017
1 min read
Save

AACR president to lead City of Hope National Medical Center

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Michael Caligiuri
Michael A. Caligiuri

Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center.

Caligiuri — president of American Association for Cancer Research — is recognized for his work in immunology, specifically the use of human natural killer cells and their role in the treatment of leukemia, myeloma and glioblastoma.

His appointment will take effect in February.

“Dr. Caligiuri is an exceptional and accomplished leader who will join and lead an extraordinary group of talented individuals singularly focused on eradicating cancer and diabetes,” Robert W. Stone, City of Hope’s president and CEO, said in a press release. “As I have come to know him, I have been struck by his innovative approach to science, high degree of humility and dedication to serving patients in need — all of which fit perfectly with City of Hope.”

Caligiuri had served as director of The Ohio State University Comprehensive Cancer Center for 14 years. He also served as CEO of The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He resigned from his leadership positions at Ohio State earlier this year.

In his new role, he will lead efforts to bring innovation into cancer care and delivery. He also will strive to optimize the patient care system while ensuring quality and safety.

“City of Hope is an incredible institution with an amazing history of innovation,” Caligiuri said in the release. “I have many friends and colleagues at City of Hope and I am incredibly excited about the organization’s vision. I share that vision and excitement for the role City of Hope will play in changing the global landscape of cancer care.”